| |
|
Form Serial Number: |
DA20221114E00323
|
| 1.
Date of relevant event: |
09/11/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
06996 |
| 4.
Name of listed corporation: |
Antengene Corporation Limited |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
660,971,644 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Mei |
| (Other names) |
Jay |
|
|
|
| 10.
Name of director (Chinese): |
|
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1711 | Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
175,927,994 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 180,597,994 | 27.32 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 180,597,994 | 27.32 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 19/11/2022 | 22/08/2030 | | | USD | 0.920 | | | 4,000,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 27/08/2023 | 26/08/2031 | | | HKD | 12.560 | | | 268,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 27/08/2024 | 26/08/2031 | | | HKD | 12.560 | | | 201,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 27/08/2025 | 26/08/2031 | | | HKD | 12.560 | | | 201,000 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| JAY MEI 2022 GRAT | N/A | Jay Mei | 100.00 | N | |
| AM & Beyond Trust | N/A | Jay Mei | 100.00 | N | |
| Meiland Pharma Tech SPC | Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | JAY MEI 2022 GRAT | 18.61 | Y | |
| Meiland Pharma Tech SPC | Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | AM & Beyond Trust | 8.52 | Y | |
| Meiland Pharma Tech SPC | Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | Jay Mei | 72.87 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| AM & Beyond Trust | Addresses of individuals are not displayed. | | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
| JAY MEI 2022 GRAT | Addresses of individuals are not displayed. | | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
(i) Dr. Jay Mei has ceased to be the trustee of the JAY MEI 2020 GRAT and JAY MEI 2022 GRAT; and (ii) after an annuity payment from JAY MEI 2020 GRAT to Dr. Jay Mei, JAY MEI 2020 GRAT ceased to hold any shares in Meiland Pharma Tech SPC and therefore is not deemed to be interested in shares of the Company held by Meiland Pharma Tech SPC.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
14/11/2022
(dd/mm/yyyy)
|
| |